These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Emerging therapies for the treatment of wet age-related macular degeneration--VEGF Trap-Eye. Rejdak R; Szkaradek M; Grieb P; Jünemann AG Klin Oczna; 2011; 113(10-12):376-8. PubMed ID: 22384659 [TBL] [Abstract][Full Text] [Related]
9. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Eyetech Study Group Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-17: The Role for Pathological Angiogenesis in Ocular Neovascular Diseases. Li Y; Zhou Y Tohoku J Exp Med; 2019 Feb; 247(2):87-98. PubMed ID: 30773517 [TBL] [Abstract][Full Text] [Related]
13. Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. Tolentino M Surv Ophthalmol; 2011; 56(2):95-113. PubMed ID: 21335144 [TBL] [Abstract][Full Text] [Related]
14. Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects. van der Giet M; Henkel C; Schuchardt M; Tolle M Curr Pharm Des; 2015; 21(24):3548-56. PubMed ID: 25714990 [TBL] [Abstract][Full Text] [Related]
15. Targeting VEGF in eye neovascularization: What's new?: A comprehensive review on current therapies and oligonucleotide-based interventions under development. Amadio M; Govoni S; Pascale A Pharmacol Res; 2016 Jan; 103():253-69. PubMed ID: 26678602 [TBL] [Abstract][Full Text] [Related]
16. Prospects for treatment of pediatric vitreoretinal diseases with vascular endothelial growth factor inhibition. Lin KL; Hirose T; Kroll AJ; Lou PL; Ryan EA Semin Ophthalmol; 2009; 24(2):70-6. PubMed ID: 19373689 [TBL] [Abstract][Full Text] [Related]
17. [Angiogenesis and antiangiogenesis in intraocular tumors]. Macovei L Oftalmologia; 2010; 54(4):24-6. PubMed ID: 21516858 [TBL] [Abstract][Full Text] [Related]
18. A brief history of anti-VEGF for the treatment of ocular angiogenesis. Kim LA; D'Amore PA Am J Pathol; 2012 Aug; 181(2):376-9. PubMed ID: 22749677 [TBL] [Abstract][Full Text] [Related]
19. Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye. Sene A; Chin-Yee D; Apte RS Trends Mol Med; 2015 Jan; 21(1):43-51. PubMed ID: 25457617 [TBL] [Abstract][Full Text] [Related]
20. Treatment of retinal diseases with VEGF antagonists. Schlingemann RO; Witmer AN Prog Brain Res; 2009; 175():253-67. PubMed ID: 19660661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]